Archive for July 2021
GVN in the News – Dr. Christian BrĂ©chot Interview with LCI, France, July 13, 2021
SARS-CoV-2 Lambda Variant: The New Kid on the Block
SARS-CoV-2 Lambda Variant: The New Kid on the Block July 19, 2021 The COVID-19 pandemic has been marked by the ongoing emergence of new genetic variants. Although SARS-CoV-2 is an RNA virus, its genome is relative stable, thanks to a proofreading polymerase. However, in a situation with extensive viral transmission globally, the evolution of SARS-CoV-2…
Read MoreGlobal Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats
Baltimore, Maryland, USA, July 15, 2021: The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en SantĂ©, de Surveillance EpidĂ©miologique et de Formation , or the IRESSEF, announced the addition of…
Read MoreGVN Center and Member Spotlight – Roman Chicz
Members > Spotlights > Roman Chicz GVN Center and Member Spotlight Roman Chicz Global Project Head Recombinant COVID Vaccine Project Sanofi What are you and your company currently working on regarding COVID-19? Sanofi is putting world-leading scientific expertise to the development of 2 vaccine candidates against COVID-19. The first is an adjuvant recombinant protein vaccine…
Read MoreDoes COVID-19 Curb or Promote the Progression of Cancer?
Does COVID-19 Curb or Promote the Progression of Cancer? July 2, 2021 One of the many questions about the long-term implications of COVID-19 is whether there might be some positive or negative consequences on cancer. The inflammatory milieu elicited by infection with SARS-CoV-2 might elicit pro-cancer effects as well as COVID-related immune-deficiency or increase DNA…
Read More